• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肾衰竭对间皮瘤肿瘤标志物 N-ERC/间皮素和骨桥蛋白的影响。

Impact of renal failure on the tumor markers of mesothelioma, N-ERC/mesothelin and osteopontin.

机构信息

Department of General Thoracic Surgery, Juntendo University School of Medicine, Tokyo, Japan.

出版信息

Anticancer Res. 2011 Apr;31(4):1427-30.

PMID:21508397
Abstract

BACKGROUND

Knowledge of the characteristics and effective use of tumour markers for mesothelioma is essential for early-stage diagnosis of mesothelioma. We examined whether renal dysfunction influences blood concentrations of promising new tumour markers, N-ERC/mesothelin (N-ERC) and osteopontin (OPN), to an important degree.

PATIENTS AND METHODS

Levels of serum N-ERC and plasma OPN in 32 patients with chronic renal dysfunction, 22 of whom were on hemodialysis (CKD group), and 102 healthy volunteers were measured.

RESULTS

Serum concentrations of N-ERC and plasma concentrations of OPN in the CKD group were significantly higher than those in volunteers, regardless of diabetes status and age. Blood concentrations of these markers increased as renal function decreased.

CONCLUSION

N-ERC and OPN concentrations are significantly influenced by renal function. Therefore, the extent of renal failure must be considered when inferring the existence of tumours and chemotherapeutic response from the values of these markers in routine practice.

摘要

背景

了解间皮瘤的特征和肿瘤标志物的有效应用对于间皮瘤的早期诊断至关重要。我们研究了肾功能不全是否会对有前途的新型肿瘤标志物 N-ERC/间皮素(N-ERC)和骨桥蛋白(OPN)的血液浓度产生重要影响。

患者和方法

检测了 32 例慢性肾功能不全患者(其中 22 例接受血液透析,即 CKD 组)和 102 名健康志愿者的血清 N-ERC 和血浆 OPN 水平。

结果

无论糖尿病状态和年龄如何,CKD 组的血清 N-ERC 浓度和血浆 OPN 浓度均明显高于志愿者。这些标志物的血液浓度随肾功能下降而升高。

结论

肾功能对 N-ERC 和 OPN 浓度有显著影响。因此,在常规实践中,从这些标志物的数值推断肿瘤的存在和化疗反应时,必须考虑肾衰竭的程度。

相似文献

1
Impact of renal failure on the tumor markers of mesothelioma, N-ERC/mesothelin and osteopontin.肾衰竭对间皮瘤肿瘤标志物 N-ERC/间皮素和骨桥蛋白的影响。
Anticancer Res. 2011 Apr;31(4):1427-30.
2
ERC/mesothelin as a marker for chemotherapeutic response in patients with mesothelioma.ERC/间皮素作为间皮瘤患者化疗反应的标志物。
Anticancer Res. 2008 Nov-Dec;28(6B):3933-6.
3
Sensitive and specific new enzyme-linked immunosorbent assay for N-ERC/mesothelin increases its potential as a useful serum tumor marker for mesothelioma.用于检测N-ERC/间皮素的灵敏且特异的新型酶联免疫吸附测定法提高了其作为间皮瘤有用血清肿瘤标志物的潜力。
Clin Cancer Res. 2008 Mar 1;14(5):1431-7. doi: 10.1158/1078-0432.CCR-07-1613.
4
Molecular tumor markers for asbestos-related mesothelioma: serum diagnostic markers.石棉相关间皮瘤的分子肿瘤标志物:血清诊断标志物
Pathol Int. 2006 Nov;56(11):649-54. doi: 10.1111/j.1440-1827.2006.02024.x.
5
Soluble mesothelin related peptides (SMRP) and osteopontin as protein biomarkers for malignant mesothelioma: analytical validation of ELISA based assays and characterization at mRNA and protein levels.可溶性间皮素相关肽 (SMRP) 和骨桥蛋白作为恶性间皮瘤的蛋白质生物标志物:ELISA 检测方法的分析验证及 mRNA 和蛋白水平的特征分析。
Clin Chem Lab Med. 2010 Feb;48(2):271-8. doi: 10.1515/CCLM.2010.066.
6
Soluble mesothelin, megakaryocyte potentiating factor, and osteopontin as markers of patient response and outcome in mesothelioma.可溶性间皮素、巨核细胞增强因子和骨桥蛋白作为间皮瘤患者反应和预后的标志物。
J Thorac Oncol. 2011 Nov;6(11):1930-7. doi: 10.1097/JTO.0b013e3182272294.
7
MESOMARK kit detects C-ERC/mesothelin, but not SMRP with C-terminus.MESOMARK检测试剂盒可检测C-ERC/间皮素,但不能检测带有C端的SMRP。
Biochem Biophys Res Commun. 2008 May 9;369(3):915-8. doi: 10.1016/j.bbrc.2008.02.114. Epub 2008 Mar 5.
8
Mesothelin and kidney function--analysis of relationship and implications for mesothelioma screening.间皮素与肾功能——关系分析及对间皮瘤筛查的意义。
Lung Cancer. 2011 Sep;73(3):320-4. doi: 10.1016/j.lungcan.2011.01.011. Epub 2011 Feb 18.
9
Utility of osteopontin and serum mesothelin in malignant pleural mesothelioma diagnosis and prognosis assessment.骨桥蛋白和血清间皮素在恶性胸膜间皮瘤诊断及预后评估中的应用价值。
Clin Cancer Res. 2007 May 15;13(10):2928-35. doi: 10.1158/1078-0432.CCR-06-2144.
10
Soluble mesothelin-related peptide level elevation in mesothelioma serum and pleural effusions.间皮瘤血清和胸腔积液中可溶性间皮素相关肽水平升高。
Ann Thorac Surg. 2008 Jan;85(1):265-72; discussion 272. doi: 10.1016/j.athoracsur.2007.07.042.

引用本文的文献

1
Serum Levels of N- and C-ERC/Mesothelin and Clinicopathological Factors in Mesothelioma Patients and Those without Mesothelioma.间皮瘤患者和非间皮瘤患者的血清N-ERC/Mesothelin和C-ERC/Mesothelin水平及临床病理因素
Juntendo Iji Zasshi. 2023 Apr 14;69(2):124-136. doi: 10.14789/jmj.JMJ22-0042-OA. eCollection 2023.
2
Circulating biomarkers in malignant pleural mesothelioma.恶性胸膜间皮瘤中的循环生物标志物
Explor Target Antitumor Ther. 2020;1(6):434-451. doi: 10.37349/etat.2020.00028. Epub 2020 Dec 28.
3
Liquid Biopsy in Malignant Pleural Mesothelioma: State of the Art, Pitfalls, and Perspectives.
恶性胸膜间皮瘤中的液体活检:现状、陷阱与展望
Front Oncol. 2019 Aug 14;9:740. doi: 10.3389/fonc.2019.00740. eCollection 2019.
4
Retrospective analysis of large-scale research screening of construction workers for the early diagnosis of mesothelioma.对建筑工人进行大规模研究筛查以早期诊断间皮瘤的回顾性分析。
Mol Clin Oncol. 2014 Jan;2(1):26-30. doi: 10.3892/mco.2013.197. Epub 2013 Oct 2.
5
Guidelines for the diagnosis and treatment of malignant pleural mesothelioma.恶性胸膜间皮瘤诊断与治疗指南。
J Thorac Dis. 2013 Dec;5(6):E254-307. doi: 10.3978/j.issn.2072-1439.2013.11.28.
6
Proteome screening of pleural effusions identifies galectin 1 as a diagnostic biomarker and highlights several prognostic biomarkers for malignant mesothelioma.胸腔积液的蛋白质组学筛选鉴定出半乳糖凝集素 1 作为一种诊断生物标志物,并突出了几种恶性间皮瘤的预后生物标志物。
Mol Cell Proteomics. 2014 Mar;13(3):701-15. doi: 10.1074/mcp.M113.030775. Epub 2013 Dec 20.
7
Serum biomarkers in patients with mesothelioma and pleural plaques and healthy subjects exposed to naturally occurring asbestos.接触天然石棉的间皮瘤和胸膜斑患者及健康受试者的血清生物标志物。
Lung. 2014 Feb;192(1):197-203. doi: 10.1007/s00408-013-9526-9. Epub 2013 Oct 30.